1.64
price down icon3.53%   -0.06
pre-market  Pre-market:  1.65   0.01   +0.61%
loading

Windtree Therapeutics Inc Stock (WINT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
11.17%
4.405
4.959 4.69 6.757 4.191
Interest Income/Expense
8.33%
0.013
0.012 0.013 0.013 0.012
Operating Income/Loss
11.17%
-4.405
-4.959 -4.69 -6.757 -4.191
Nonoperating Income/Loss
7,658%
14.74
-0.195 0.265 0.156 0.08
Income/Loss From Continuing Operations Before Tax
300.49%
10.33
-5.154 -4.425 -6.601 -4.111
Income Tax Expense/Benefit
0.114
- - - -
Income/Loss From Continuing Operations After Tax
298.27%
10.22
-5.154 -4.425 -6.601 -4.111
Net Income/Loss
298.27%
10.22
-5.154 -4.425 -6.601 -4.111
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9.36%
0.465
0.513 5.148 4.03 0.863
Basic Earnings Per Share
3,070%
21.98
-0.74 -0.86 -1.64 -4.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.69
price up icon 1.46%
$308.02
price down icon 0.90%
$31.65
price up icon 0.29%
$20.60
price up icon 3.57%
$95.40
price down icon 0.52%
biotechnology ONC
$262.60
price up icon 4.65%
Cap:     |  Volume (24h):